![Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues. - ppt download Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues. - ppt download](https://images.slideplayer.com/13/3813471/slides/slide_4.jpg)
Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues. - ppt download
![1 Investigator-Initiated Clinical Research Planning, Developing, Conducting, Managing, and Succeeding Wm. Hirschhorn, M.S. Director, OCT & RQI and Adj. - ppt download 1 Investigator-Initiated Clinical Research Planning, Developing, Conducting, Managing, and Succeeding Wm. Hirschhorn, M.S. Director, OCT & RQI and Adj. - ppt download](https://slideplayer.com/4798387/15/images/slide_1.jpg)
1 Investigator-Initiated Clinical Research Planning, Developing, Conducting, Managing, and Succeeding Wm. Hirschhorn, M.S. Director, OCT & RQI and Adj. - ppt download
![MJA on Twitter: "Value proposition of investigator‐initiated clinical trials conducted by networks … #freeaccess 1 week … "Investigator‐initiated trials run by clinical trial networks provide net economic benefits to health systems" https://t.co ... MJA on Twitter: "Value proposition of investigator‐initiated clinical trials conducted by networks … #freeaccess 1 week … "Investigator‐initiated trials run by clinical trial networks provide net economic benefits to health systems" https://t.co ...](https://pbs.twimg.com/media/EuAZUVEUYAMfpWJ.jpg)
MJA on Twitter: "Value proposition of investigator‐initiated clinical trials conducted by networks … #freeaccess 1 week … "Investigator‐initiated trials run by clinical trial networks provide net economic benefits to health systems" https://t.co ...
![Investigator-initiated trials of targeted oncology agents: why independent research is at risk? | Semantic Scholar Investigator-initiated trials of targeted oncology agents: why independent research is at risk? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d41664533a3e1c07707bf920ad698a5a6ae7b1c3/3-Table1-1.png)
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? | Semantic Scholar
![Prior Consultation Timeframes for Investigator—Initiated Clinical Trial Applications | NIH: National Institute of Allergy and Infectious Diseases Prior Consultation Timeframes for Investigator—Initiated Clinical Trial Applications | NIH: National Institute of Allergy and Infectious Diseases](https://www.niaid.nih.gov/sites/default/files/iictpreapplication.jpg)
Prior Consultation Timeframes for Investigator—Initiated Clinical Trial Applications | NIH: National Institute of Allergy and Infectious Diseases
![Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/424ca98b-0673-4b87-bef8-067f7daf4b4d/gr1.jpg)